Floatz logo

Autologous Cd19-Cd8-Cd28-Cd3Zeta-Car-Mbil15-Her1T T Cells

B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged

M.D. Anderson Cancer CenterCell therapyPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
M.D. Anderson Cancer Center
Phase 1CC
Fludarabine
M.D. Anderson Cancer Center
Phase 1CC

Same molecule, other indications

Autologous Cd19-Cd8-Cd28-Cd3Zeta-Car-Mbil15-Her1T T Cells is also rated in:

B-cell acute lymphoblastic leukemiaDormant
CC
Indicative ·
43 / 100
View asset →
relapsed/refractory diffuse large B-cell lymphomaDormant
CC
Indicative ·
43 / 100
View asset →
mantle cell lymphomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →